Antibodies against the CLR/RAMP1 extracellular domains block CGRP binding and function in vitro.
Antibodies display specificity in Western blot and immunohistochemistry applications.
Immunohistochemistry localizes CGRP receptors at key sites in the trigeminovascular system.